Mapping the Multi-Omic Era with Eric Green of Illumina
About this episode
Dr. Eric Green discusses the importance of multi-omic approaches in genomics and clinical diagnostics.
Dr. Eric Green returns to Mendelspod in a new role: Chief Medical Officer of Illumina. After more than three decades at the National Human Genome Research Institute, where he helped guide genomics from research initiatives to clinical reality, he now joins one of the industry’s most influential companies at a moment when the field is expanding beyond DNA alone. Green takes us on a tour around the world of multi-omics, which he says is not a branding exercise but a practical response to the limits of sequence data by itself. Genomics remains foundational, but many clinical questions require additional layers of biology, including RNA, epigenomics, proteomics, and single-cell analysis. As he puts it, “DNA sequence alone may not reveal it.” The discussion highlights rare disease as one of the clearest examples. Genome sequencing can solve roughly half of suspected cases, Green notes, but many patients remain undiagnosed because the relevant signal may lie in RNA splicing, epigenetic regulation, structural variation, or downstream protein effects. In those settings, multi-omic approaches can provide the missing evidence needed to move from uncertainty to diagnosis. In oncology, the…
More episodes of Mendelspod Podcast
- Building the Diagnostic Layer of Modern Cancer Care with Rita Shaknovich and Karina Kulangara of Agilent
- Inside Proteomics at Thermo Fisher with Yan Zhang
- Separating Epigenetic Signals Improves Early Cancer Detection with Rob Osborne, Biomodal
- Digital Controls for Cancer Drug Trials? Irina Babina, Concr
Explore listener stats, chart rankings, contacts and more on the Mendelspod Podcast podcast page.